Clinical Trial Update: UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of UFUR plus thalidomide for advanced hepatocellular carcinoma (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thalidomide (thalidomide)
• UFUR (tegafur/uracil)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED